ARAY

Accuray Incorporated

0.43

USD

ARAY Earnings Reports

Positive Surprise Ratio

ARAY beat 24 of 40 last estimates.

60%

Next Report

Date of Next Report

Apr 28, 2026

Estimate for Q3 26 (Revenue/ EPS)

$114.14M

-$0.04

Implied change from Q2 26 (Revenue/ EPS)

+11.64%

-63.64%

Implied change from Q3 25 (Revenue/ EPS)

+0.79%

+300.00%

Accuray Incorporated earnings per share and revenue

On Feb 04, 2026, ARAY reported earnings of -0.11 USD per share (EPS) for Q2 26, beating the estimate of -0.11 USD, resulting in a 1.96% surprise. Revenue reached 102.24 million, compared to an expected 102.87 million, with a -0.61% difference. The market reacted with a -20.68% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 4 analysts forecast an EPS of -0.04 USD, with revenue projected to reach 114.14 million USD, implying an decrease of -63.64% EPS, and increase of 11.64% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Alpha Tau Medical Ltd. Ordinary Shares

Report Date

Mar 09, 2026 For Q4 25

Estimate

-$0.12

Actual

-$0.08

Surprise

+36.51%

Neuropace, Inc. Common Stock

Report Date

Mar 03, 2026 For Q4 25

Estimate

-$0.15

Actual

-$0.08

Surprise

+48.22%

OrthoPediatrics Corp. Common Stock

Report Date

Feb 26, 2026 For Q4 25

Estimate

-$0.34

Actual

-$0.43

Surprise

-25.36%

Delcath Systems Inc

Report Date

Feb 26, 2026 For Q4 25

Estimate

-$0.06

Actual

-$0.05

Surprise

+20.51%

Sight Sciences, Inc. Common Stock

Report Date

Mar 04, 2026 For Q4 25

Estimate

-$0.14

Actual

-$0.08

Surprise

+43.66%

908 Devices Inc. Common Stock

Report Date

Mar 03, 2026 For Q4 25

Estimate

-$0.07

Actual

$0.10

Surprise

+240.06%

Anteris Technologies Global Corp. Common Stock

Report Date

Feb 26, 2026 For Q4 25

Estimate

-$0.59

Actual

-$0.74

Surprise

-24.18%

Stereotaxis, Inc. Common Stock

Report Date

Mar 09, 2026 For Q4 25

Estimate

-$0.06

Actual

-$0.06

Surprise

+10.04%

Rapid Micro Biosystems, Inc. Class A Common Stock

Report Date

Mar 12, 2026 For Q4 25

Estimate

-$0.22

Actual

-$0.28

Surprise

-23.35%

Treace Medical Concepts, Inc. Common Stock

Report Date

Feb 27, 2026 For Q4 25

Estimate

-$0.15

Actual

-$0.15

Surprise

+1.96%

FAQ

What were Accuray Incorporated's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Accuray Incorporated reported EPS of -$0.11, beating estimates by 1.96%, and revenue of $102.24M, -0.61% below expectations.

How did the market react to Accuray Incorporated's Q2 2026 earnings?

The stock price moved down -20.68%, changed from $0.76 before the earnings release to $0.60 the day after.

When is Accuray Incorporated expected to report next?

The next earning report is scheduled for Apr 28, 2026.

What are the forecasts for Accuray Incorporated's next earnings report?

Based on 4 analysts, Accuray Incorporated is expected to report EPS of -$0.04 and revenue of $114.14M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.